Kitov Pharmaceuticals Hldgs L Sponsored ADR (KTOV)

[midastouch017]

Kitov Pharma latest biotech breakout, shares up 37%

Oct. 11, 2017 3:03 PM ET|About: Kitov Pharmaceuticals ... (KTOV)|By: Douglas W. House, SA News Editor
Thinly traded nano cap Kitov Pharmaceuticals Holdings (KTOV +36.6%) joins the ever-growing list of biotech breakouts on more than an 18x surge in volume. No particular news accounts for the action.

Last week the company announced an additional 27% stake in TyrNovo with promising cancer candidate NT219 and the submission of its U.S. marketing application for combo med KIT-302.

Previously: Kitov ups stake in oncology-focused TyrNovo to 92%; shares ahead 9% premarket (Oct. 6)

Previously: Kitov files U.S. marketing application for lead candidate KIT-302; shares ahead 8% premarket (Oct. 2)

https://seekingalpha.com/news/3300500-kitov-pharma-latest-biotech-breakout-shares-37-percent?app=1&uprof=45&dr=1#email_link